Mark D. King

2.9k total citations · 2 hit papers
18 papers, 2.2k citations indexed

About

Mark D. King is a scholar working on Infectious Diseases, Clinical Biochemistry and Epidemiology. According to data from OpenAlex, Mark D. King has authored 18 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 7 papers in Clinical Biochemistry and 5 papers in Epidemiology. Recurrent topics in Mark D. King's work include Bacterial Identification and Susceptibility Testing (6 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). Mark D. King is often cited by papers focused on Bacterial Identification and Susceptibility Testing (6 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). Mark D. King collaborates with scholars based in United States, Ireland and United Kingdom. Mark D. King's co-authors include Ekaterina V. Kourbatova, Henry M. Blumberg, Susan M. Ray, Yun F. Wang, Ulrich Seybold, H. M. Blumberg, Jeremiah G. Johnson, J. Sue Halvosa, Alicia Hidrón and Fred C. Tenover and has published in prestigious journals such as Annals of Internal Medicine, Clinical Infectious Diseases and Infection Control and Hospital Epidemiology.

In The Last Decade

Mark D. King

18 papers receiving 2.1k citations

Hit Papers

Emergence of Community-Acquired Methicillin-Resistant Sta... 2006 2026 2012 2019 2006 2006 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark D. King United States 13 1.6k 916 590 557 539 18 2.2k
Ekaterina V. Kourbatova United States 13 1.6k 1.0× 922 1.0× 556 0.9× 536 1.0× 453 0.8× 21 2.0k
Anusha Krishnadasan United States 21 2.1k 1.3× 1.3k 1.4× 1.1k 1.9× 624 1.1× 591 1.1× 38 3.1k
Samantha J. Eells United States 25 1.1k 0.7× 633 0.7× 511 0.9× 344 0.6× 425 0.8× 40 1.7k
Keryn Christiansen Australia 25 1.3k 0.8× 716 0.8× 267 0.5× 525 0.9× 927 1.7× 49 2.2k
Kathryn Como‐Sabetti United States 16 1.3k 0.8× 702 0.8× 740 1.3× 384 0.7× 482 0.9× 34 1.9k
Elizabeth A. Grabsch Australia 21 1.3k 0.8× 806 0.9× 257 0.4× 319 0.6× 358 0.7× 33 1.7k
Wendy Munckhof Australia 20 1.0k 0.7× 635 0.7× 338 0.6× 300 0.5× 491 0.9× 42 1.7k
Laurie Thomson Sanza United States 8 1.5k 1.0× 582 0.6× 518 0.9× 347 0.6× 755 1.4× 8 1.9k
Kathleen Riederer United States 22 1.1k 0.7× 831 0.9× 415 0.7× 305 0.5× 575 1.1× 55 1.6k
Kyle J. Popovich United States 25 1.3k 0.8× 609 0.7× 303 0.5× 261 0.5× 461 0.9× 56 1.7k

Countries citing papers authored by Mark D. King

Since Specialization
Citations

This map shows the geographic impact of Mark D. King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. King more than expected).

Fields of papers citing papers by Mark D. King

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark D. King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. King. The network helps show where Mark D. King may publish in the future.

Co-authorship network of co-authors of Mark D. King

This figure shows the co-authorship network connecting the top 25 collaborators of Mark D. King. A scholar is included among the top collaborators of Mark D. King based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark D. King. Mark D. King is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
King, Mark D., et al.. (2010). Decoding the Miss Daisy Syndrome: An Examination of Subjective Responses to Mobility Change. Journal of Gerontological Social Work. 54(1). 29–52. 35 indexed citations
2.
Morano, Carmen & Mark D. King. (2010). Lessons learned from implementing a psycho-educational intervention for African American dementia caregivers. Dementia. 9(4). 558–568. 8 indexed citations
3.
Camins, Bernard, et al.. (2009). Impact of an Antimicrobial Utilization Program on Antimicrobial Use at a Large Teaching Hospital A Randomized Controlled Trial. Infection Control and Hospital Epidemiology. 30(10). 931–938. 108 indexed citations
4.
King, Mark D., et al.. (2009). O5-5 Benign non epileptic episodic contractions in infancy: novel aspects recognised on video recordings. European Journal of Paediatric Neurology. 13. S12–S12. 1 indexed citations
5.
Seybold, Ulrich, Ekaterina V. Kourbatova, Jeremiah G. Johnson, et al.. (2006). Emergence of Community-Associated Methicillin-Resistant Staphylococcus aureus USA300 Genotype as a Major Cause of Health Care--Associated Blood Stream Infections. Clinical Infectious Diseases. 42(5). 647–656. 549 indexed citations breakdown →
6.
King, Mark D., et al.. (2006). Emergence of Community-Acquired Methicillin-Resistant Staphylococcus aureus USA 300 Clone as the Predominant Cause of Skin and Soft-Tissue Infections. Annals of Internal Medicine. 144(5). 309–317. 623 indexed citations breakdown →
7.
Rouphael, Nadine, et al.. (2006). Polymyxin B and Doxycycline Use in Patients with Multidrug-Resistant Acinetobacter baumannii Infections in the Intensive Care Unit. Annals of Pharmacotherapy. 40(11). 1939–1945. 70 indexed citations
8.
Hidrón, Alicia, Ekaterina V. Kourbatova, J. Sue Halvosa, et al.. (2005). Risk Factors for Colonization with Methicillin‐ResistantStaphylococcus aureus(MRSA) in Patients Admitted to an Urban Hospital: Emergence of Community‐Associated MRSA Nasal Carriage. Clinical Infectious Diseases. 41(2). 159–166. 272 indexed citations
9.
Kourbatova, Ekaterina V., J. Sue Halvosa, Mark D. King, et al.. (2005). Emergence of community-associated methicillin-resistant Staphylococcus aureus USA 300 clone as a cause of health care-associated infections among patients with prosthetic joint infections. American Journal of Infection Control. 33(7). 385–391. 156 indexed citations
10.
Seybold, Ulrich, et al.. (2005). 299 EMERGENCE OF COMMUNITY-ASSOCIATED METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS USA300 GENOTYPE IN HEALTH CARE-ASSOCIATED BLOODSTREAM INFECTIONS. Journal of Investigative Medicine. 53(1). S306.2–S306. 2 indexed citations
11.
Jasmer, Robert M., David C. Snyder, Jussi Saukkonen, et al.. (2004). Short‐Course Rifampin and Pyrazinamide Compared with Isoniazid for Latent Tuberculosis Infection: A Cost‐Effectiveness Analysis Based on a Multicenter Clinical Trial. Clinical Infectious Diseases. 38(3). 363–369. 22 indexed citations
12.
Hartley, Louise, Zarazuela Zolkipli, Mark A. Little, et al.. (2004). Short-Chain Acyl-CoA Dehydrogenase Deficiency Associated with Early Onset Severe Axonal Neuropathy. Neuropediatrics. 35(5). 312–316. 15 indexed citations
13.
Tobin‐D’Angelo, Melissa, et al.. (2004). Dapsone-Induced Hypersensitivity Pneumonitis Mimicking Pneumocystis carinii Pneumonia in a Patient with AIDS. The American Journal of the Medical Sciences. 327(3). 163–165. 9 indexed citations
14.
King, Mark D., et al.. (2003). An Unusual Case of Benign Reflex Myoclonic Epilepsy of Infancy. Neuropediatrics. 34(3). 152–155. 8 indexed citations
15.
King, Mark D., et al.. (2003). Recurrent Invasive Pneumococcal Disease: A Population-Based Assessment. Clinical Infectious Diseases. 37(8). 1029–1036. 33 indexed citations
17.
King, Mark D., Carl A. Perlino, Jay Cinnamon, & John A. Jernigan. (2002). Paradoxical recurrent meningitis following therapy of cryptococcal meningitis: an immune reconstitution syndrome after initiation of highly active antiretroviral therapy. International Journal of STD & AIDS. 13(10). 724–726. 59 indexed citations
18.
Jasmer, Robert M., Jussi Saukkonen, Henry M. Blumberg, et al.. (2002). Short-Course Rifampin and Pyrazinamide Compared with Isoniazid for Latent Tuberculosis Infection: A Multicenter Clinical Trial. Annals of Internal Medicine. 137(8). 640–647. 146 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026